| Not Yet Recruiting | Cervical Cytology DNA Methylation for Endometrial Lesion Screening and Follow-up NCT07298707 | Peking Union Medical College Hospital | — |
| Recruiting | The Role of POLE Mutation in High Risk Endometrial Cancer. NCT07114653 | Far Eastern Memorial Hospital | — |
| Recruiting | A Study of LY4257496 in Participants With Cancer (OMNIRAY) NCT07114601 | Eli Lilly and Company | Phase 1 |
| Recruiting | A Study of LY4175408 in Participants With Advanced Cancer NCT07046923 | Eli Lilly and Company | Phase 1 |
| Recruiting | Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in NCT07040657 | Dokuz Eylul University | N/A |
| Active Not Recruiting | Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors NCT06714617 | SystImmune Inc. | Phase 1 |
| Recruiting | A Study of DM002 in Patients With Advanced Solid Tumors NCT06751329 | Xadcera Biopharmaceutical (Suzhou) Co., Ltd. | Phase 1 |
| Recruiting | A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors NCT06586957 | NiKang Therapeutics, Inc. | Phase 1 |
| Recruiting | First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab NCT06502743 | Yonsei University | Phase 2 |
| Not Yet Recruiting | Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma NCT06521684 | Peking Union Medical College Hospital | — |
| Recruiting | Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma NCT06532539 | Shandong Cancer Hospital and Institute | Phase 2 |
| Not Yet Recruiting | Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer NCT06363708 | Zhongnan Hospital | N/A |
| Recruiting | A Study of LY4170156 in Participants With Selected Advanced Solid Tumors NCT06400472 | Eli Lilly and Company | Phase 1 |
| Terminated | A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors NCT06264921 | NiKang Therapeutics, Inc. | Phase 1 |
| Unknown | Effect of Stress Ball Use on Anxiety Level During Endometrial Biopsy Procedure NCT06171581 | Zonguldak Bulent Ecevit University | N/A |
| Recruiting | A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy NCT06023862 | Yonsei University | Phase 2 |
| Not Yet Recruiting | MRI Radiomics Combined With Pathomics on the Prediction of Molecular Classification and Prognosis of Endometri NCT06126393 | Fujian Cancer Hospital | — |
| Active Not Recruiting | A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 NCT06003231 | Seagen, a wholly owned subsidiary of Pfizer | Phase 2 |
| Recruiting | Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair D NCT05795244 | Yonsei University | Phase 2 |
| Recruiting | DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Canc NCT05770102 | Cancer Research UK | Phase 2 / Phase 3 |
| Enrolling By Invitation | POLE-END REAL LIFE: Endometrial Cancer Early Stages I-II and Advanced Stages III and IV Evaluation of POLE as NCT06409039 | Azienda Ulss 2 Marca Trevigiana | — |
| Recruiting | Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer NCT05974995 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | N/A |
| Recruiting | Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy NCT05793749 | Chongqing University Cancer Hospital | N/A |
| Recruiting | Uterine Manipulator Versus No Uterine Manipulator in Endometrial Cancer Trial NCT05687084 | Universita di Verona | N/A |
| Recruiting | Inflammatory Index as a Predictor for Endometrial Cancer: an Observational Study NCT05657483 | University of Campania Luigi Vanvitelli | — |
| Unknown | An Observational Study Based on Endometrial Cancer Risk Screening Model NCT05634798 | Peking Union Medical College Hospital | — |
| Unknown | The Impact of Epigenetic MMRd in Endometrial carcinomas-a Real World Study NCT05334303 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Active Not Recruiting | Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer NCT05869123 | Peking Union Medical College Hospital | Phase 1 / Phase 2 |
| Active Not Recruiting | Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervi NCT05682950 | Peking Union Medical College Hospital | Phase 2 |
| Recruiting | GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients NCT06379113 | Xiaojun Chen | Phase 2 / Phase 3 |
| Recruiting | GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients NCT05316935 | Xiaojun Chen | Phase 2 / Phase 3 |
| Terminated | A Study of SGN-ALPV in Advanced Solid Tumors NCT05229900 | Seagen Inc. | Phase 1 |
| Active Not Recruiting | Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent NCT05173987 | Merck Sharp & Dohme LLC | Phase 3 |
| Terminated | A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors NCT05194072 | Seagen, a wholly owned subsidiary of Pfizer | Phase 1 |
| Recruiting | Registry Platform Ovarian and Endometrial Cancer NCT05129969 | iOMEDICO AG | — |
| Terminated | A Study of PF-07260437 in Advanced or Metastatic Solid Tumors NCT05067972 | Pfizer | Phase 1 |
| Unknown | Endometrial Lesions Predictions NCT05588076 | Beijing Friendship Hospital | — |
| Completed | MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) NCT05007106 | Merck Sharp & Dohme LLC | Phase 2 |
| Terminated | A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) NCT05001282 | Elucida Oncology | Phase 1 / Phase 2 |
| Recruiting | Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) NCT04956640 | Eli Lilly and Company | Phase 1 / Phase 2 |
| Completed | Real-time Lymphatic Channel Visualization Improves Bilateral Sentinel Lymph Node Detection in Endometrial Canc NCT05191212 | Bakirkoy Dr. Sadi Konuk Research and Training Hospital | N/A |
| Completed | Effect of Pelvic Radiotherapy on the Intestinal Microbiome and Metabolome NCT04995809 | The Christie NHS Foundation Trust | — |
| Completed | [SENTRY] Tailoring Postoperative Management Through Sentinel Lymph Node Biopsy in Low- and Intermediate-Risk E NCT04972682 | Moscow City Oncology Hospital No. 62 | N/A |
| Completed | A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients NCT05375136 | Eisai Korea Inc. | — |
| Unknown | HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding NCT04867109 | Nantes University Hospital | — |
| Completed | Study of AK112 in the Treatment of Advanced Gynecological Tumors NCT04870177 | Akeso | Phase 2 |
| Completed | Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer NCT04763902 | University of Utah | N/A |
| Terminated | A Study of SGN-STNV in Advanced Solid Tumors NCT04665921 | Seagen Inc. | Phase 1 |
| Active Not Recruiting | Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Par NCT04634877 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors NCT03935282 | Wake Forest University Health Sciences | N/A |
| Completed | COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors. NCT04570839 | Compugen Ltd | Phase 1 / Phase 2 |
| Active Not Recruiting | Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurren NCT04269200 | AstraZeneca | Phase 3 |
| Recruiting | The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter NCT04403867 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | — |
| Completed | Endometrial Malignancy in Breast Cancer Patients With or Without AUB NCT05977829 | University of Campania Luigi Vanvitelli | — |
| Completed | Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique NCT03766672 | University Hospital Center of Martinique | — |
| Completed | Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-e NCT04865289 | Merck Sharp & Dohme LLC | Phase 3 |
| Active Not Recruiting | A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor NCT04008797 | Eisai Inc. | Phase 1 / Phase 2 |
| Unknown | Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer NCT03951415 | Leiden University Medical Center | Phase 2 |
| Completed | Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-e NCT03884101 | Merck Sharp & Dohme LLC | Phase 3 |
| Unknown | Sentinel Lymph Node Mapping In Endometrial Cancer NCT03778255 | Peking University People's Hospital | N/A |
| Completed | Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advan NCT03517449 | Eisai Inc. | Phase 3 |
| Completed | Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer NCT03276013 | Vall d'Hebron Institute of Oncology | Phase 2 |
| Unknown | Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Pacli NCT03570437 | University of Manchester | Phase 2 |
| Completed | Correlation Between Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination NCT03917147 | University of Campania Luigi Vanvitelli | — |
| Terminated | CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physicia NCT02900248 | CureOne | — |
| Unknown | Survival Outcomes of Uterine Malignancies in Chinese Population NCT03291275 | Lei Li | — |
| Unknown | Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer NCT03291106 | Lei Li | — |
| Unknown | Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cance NCT03543215 | Imperial College London | — |
| Completed | Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue? NCT03207074 | Imperial College London | N/A |
| Completed | Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy? NCT03207126 | Imperial College London | N/A |
| Unknown | Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer? NCT03207061 | Imperial College London | N/A |
| Unknown | Serum Biomarkers in Diagnosis and Predicting Prognosis of Ovarian Cancers NCT03112733 | Ilker Kahramanoglu | — |
| Withdrawn | Lenvatinib in Second Line Endometrial Carcinoma NCT03005015 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Recruiting | Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer NCT05945407 | Peking University People's Hospital | N/A |
| Unknown | HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life NCT03000192 | University Hospital Southampton NHS Foundation Trust | — |
| Completed | A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib NCT02725268 | Millennium Pharmaceuticals, Inc. | Phase 2 |
| Completed | Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer NCT02564276 | Centre hospitalier de l'Université de Montréal (CHUM) | Phase 3 |
| Withdrawn | Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma NCT01888562 | Washington University School of Medicine | N/A |
| Unknown | Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer NCT02494791 | University Health Network, Toronto | N/A |
| Unknown | The Feasibility Study of the Li Brush for the Screening of Endometrial Cancer in the Postmenopausal Period NCT02512848 | First Affiliated Hospital Xi'an Jiaotong University | — |
| Completed | Diet and Physical Activity in Uterine Cancer Survivors NCT02433080 | University College, London | N/A |
| Completed | Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study NCT03270995 | McGill University | N/A |
| Completed | STELLA 2 Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian C NCT02676726 | Hospital Universitari Vall d'Hebron Research Institute | N/A |
| Completed | Sentinel Lymph Node Detection in Endometrial Cancer NCT02690259 | Region Skane | N/A |
| Completed | LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial Carcinoma NCT02387645 | Medical University of Vienna | N/A |
| Recruiting | DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics NCT02288676 | McGill University | — |
| Terminated | Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology NCT01969396 | Cook Group Incorporated | N/A |
| Completed | Robotic Versus Abdominal Surgery for Endometrial Cancer NCT01847703 | Karolinska Institutet | N/A |
| Active Not Recruiting | The Safety of Ovarian Preservation in Stage IA Endometrial Carcinoma NCT01820884 | Ding Ma | N/A |
| Active Not Recruiting | The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial NCT01820858 | Ding Ma | Phase 3 |
| Completed | [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers NCT01717391 | John M. Buatti | Phase 2 |
| Completed | STELLA Trial: Transperitoneal vs. Extraperitoneal Approach for Laparoscopic Staging of Endometrial/Ovarian Can NCT01810874 | Hospital Universitari Vall d'Hebron Research Institute | N/A |
| Terminated | A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial C NCT01420081 | Pfizer | Phase 2 |
| Completed | Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced E NCT01460979 | AGO Study Group | Phase 2 |
| Unknown | Early Detection of Cancers in Low Resource Countries NCT01178736 | Woman's Cancer Foundation | — |
| Completed | Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma NCT01013324 | Sanofi | Phase 2 |
| Terminated | Sleep and Endometrial Cancer NCT00936598 | University of Pittsburgh | N/A |
| Completed | Cost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic On NCT02865889 | Institut Paoli-Calmettes | — |
| Completed | Sentinel Node and Endometrial Cancer NCT00987051 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | A Trial for Patients With Advanced/Recurrent Endometrial Cancer NCT00377520 | Eli Lilly and Company | Phase 2 |
| Unknown | Tissue Bank of Biological Specimens From Patients With Gynecologic Disease NCT00299481 | U.S. Army Medical Research and Development Command | — |
| Unknown | Questionnaire Study for Gynecological Cancer Survivors NCT00391664 | U.S. Army Medical Research and Development Command | — |
| Completed | Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology NCT00288821 | UMC Utrecht | — |
| Completed | Mixture of Prebiotics on Intestinal Microbiota of Patients Receiving Abdominal Radiotherapy. NCT01549782 | Hospital General Universitario Gregorio Marañon | N/A |
| Completed | Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma NCT00050440 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 2 |
| Completed | Pre-Clinical Models in Gynecological Tumors A Tissue Repository NCT00250783 | University of New Mexico | — |
| Unknown | Molecular Markers in Treatment in Endometrial Cancer NCT00598845 | University of Bergen | — |
| Completed | Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer NCT02724501 | University Health Network, Toronto | — |
| Completed | Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions W NCT00341458 | National Cancer Institute (NCI) | — |
| Withdrawn | Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis NCT00250770 | University of New Mexico | — |
| Unknown | Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers NCT00178802 | The University of Texas Health Science Center, Houston | Phase 2 |